SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO., LTD.

News Shanghai Haohai Biological Technology Co., Ltd. Shanghai S.E.

Equities

688366

CNE100003NX4

End-of-day quote Shanghai S.E. Other stock markets 18:00:00 2024-05-19 EDT			5-day change	1st Jan Change
92.45 ^CNY	+0.84%		-0.05%	-14.63%

04-29	Shanghai Haohai Biological Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
03-11	Shanghai Haohai's 2023 Profit Rises on Higher Revenue; Shares Rise 5%	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Shanghai Haohai Biological Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-29	CI
Shanghai Haohai's 2023 Profit Rises on Higher Revenue; Shares Rise 5%	03-11	MT
Shanghai Haohai Biological Technology Co., Ltd. Proposes Final Dividend for the Year Ended December 31, 2023, Payable on July 19, 2024	03-08	CI
Shanghai Haohai Biological Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	02-23	CI
Shanghai Haohai Biological Forecasts Up to 138% Boost in 2023 Profit	01-29	MT
Shanghai Haohai Biological Technology Co., Ltd. Provides Preliminary Unaudited Consolidated Group Earnings Guidance for the Year Ended 31 December 2023	01-29	CI
Tranche Update on Shanghai Haohai Biological Technology Co., Ltd.'s Equity Buyback Plan announced on September 27, 2023.	01-02	CI
Shanghai Haohai Biological Technology Co., Ltd. Announces Resignation of Guo Yongqing as Independent Non-Executive Director, Chairman of Audit Committee, Member of Remuneration and Appraisal Committee and Member of Nomination Committee	12-01	CI
Haohai Biological Technology's Q3 Profit Rises 34%; Hong Kong Shares Jump 5%	23-10-26	MT
Shanghai Haohai Biological Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-25	CI
Tranche Update on Shanghai Haohai Biological Technology Co., Ltd.'s Equity Buyback Plan announced on September 27, 2023.	23-10-09	CI
Shanghai Haohai Biological Technology Co., Ltd. commences an Equity Buyback Plan for 1,538,461 shares, representing 0.9% for CNY 200 million, under the auhtorization approved on September 15, 2023.	23-09-26	CI
Shanghai Haohai Biological Technology to See Rise in January-September Profit	23-09-25	MT
Shanghai Haohai Biological Technology Co., Ltd. Provides Unaudited Consolidated Financial Guidance for the Nine Months Ended 30 September 2023	23-09-25	CI
Shanghai Haohai Biological Technology's Profit Surges 188.9% in H1; Shares Up 3%	23-08-18	MT
Shanghai Haohai Biological Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-17	CI
Shanghai Haohai Biological Technology Co., Ltd. authorizes a Buyback Plan.	23-08-16	CI
Shanghai Haohai Biological to Buy Remaining Stake in Medical Aesthetics, Cosmetology Business	23-08-01	MT
Shanghai Haohai Biological Technology Co., Ltd. entered into the equity transfer agreement to acquire 36.3636% stake in OHMK Medical Technology Co., Ltd. from Tianjin Huacan Enterprise Management Consulting Partnership, Shanghai Ermei Enterprise Management Consulting Partnership, Yuan Yibing, Lian Songyong and Chen Guangfei for approximately CNY 150 million.	23-07-31	CI
Shanghai Haohai Biological Technology’s H1 Profit to See Up to 210% Boost	23-07-21	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Shanghai Haohai Biological Technology Co., Ltd. Shanghai S.E.

Equities

688366

CNE100003NX4

Summary

Filters